- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01933100
Comparison of Rice Based-meal on Functional Constipation in Young Korean Women
December 20, 2019 updated by: Soo-Wan Chae, Chonbuk National University Hospital
Comparison of Brown Rice Based-meal or Polished Rice Based-meal or Wheat Based-meal on Functional Constipation in Young Korean Women: A Opened, Clinical Trial
This study was conducted to investigate the effects of rice based-meal on functional constipation in young Korean women.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Studies comparing and evaluating the effects of a rice-based diet and a wheat-based diet on bowel movements are insufficient.
In summary, efficient measures are needed to help individuals consume enough dietary fiber from natural sources in daily life to improve their bowel movements, rather than to consume a fiber supplements separated or synthesized from a particular natural food.
In this study, investigators compare and evaluate the effects and safety of eating rice-based diets (brown rice-based and white rice-based) and a wheat-based diet in terms of bowel health and bowel movements among young women with functional constipation.
Study Type
Interventional
Enrollment (Actual)
39
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jeollabuk-do
-
Jeonju, Jeollabuk-do, Korea, Republic of, 560-822
- Clinical Trial Center for Functional Foods
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 30 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Age of 19 to 30 years females
- Meet of Rome Ⅲ diagnostic criteria of functional constipation
- Ability to give informed consent
Exclusion Criteria:
- Subject with a history or evidence of clinically significant gastrointestinal, anorectal, hepatic, renal, neurological, pulmonary, endocrine, blood tumor, psychiatric, cardiovascular disease
- Subjects who have a gastrointestinal (GI) disease (Crohn's disease, etc.) that would increase the influence with absorbance medication or a GI surgery excluding appendectomy and hernia surgery
- Known history of moderate to severe hepatic impairment (i.e., serum ALT>1.5×ULN, AST>1.5×ULN)
- Subjects with significant hypersensitivity about brown rice, polished rice, wheat, milk
- Regular ingestion of probiotic products
- Subjects who received certain medications that cause the alteration of bowel movement within the past 2weeks prior to first administration
- Subjects who participated in other clinical investigation within 2 months prior to first administration
- Subject who drink constantly (21 units/week over)
- Subject who are pregnant or breast feeding
- Subject who have irritable bowel syndrome by ROME Ⅲ criteria
- Any significant condition that, in the opinion of the investigator, could interfere with the subject's participation or compliance in the study(i.e., laboratory test and others)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Brown Rice Based-Meal
Macronutrient composition of experimental diet were carbohydrate 55~70%, protein 7~20%, fat 15~25%, fiber provided by the experimental diet was designed to adequate intake 20g/day for women
|
Macronutrient composition of experimental diet were carbohydrate 55~70%, protein 7~20%, fat 15~25%, fiber provided by the experimental diet was designed to adequate intake 20g/day for women
|
|
Experimental: Polished Rice Based-Meal
Macronutrient composition of experimental diet were carbohydrate 55~70%, protein 7~20%, fat 15~25%, fiber provided by the experimental diet was designed to adequate intake 20g/day for women
|
Macronutrient composition of experimental diet were carbohydrate 55~70%, protein 7~20%, fat 15~25%, fiber provided by the experimental diet was designed to adequate intake 20g/day for women
|
|
Experimental: Wheat Based-Meal
Macronutrient composition of experimental diet were carbohydrate 55~70%, protein 7~20%, fat 15~25%, fiber provided by the experimental diet was designed to adequate intake 20g/day for women
|
Macronutrient composition of experimental diet were carbohydrate 55~70%, protein 7~20%, fat 15~25%, fiber provided by the experimental diet was designed to adequate intake 20g/day for women
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total colon transit time
Time Frame: 0, 28 days from the start of the study
|
Hour of total colonic transit
|
0, 28 days from the start of the study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stool frequency
Time Frame: 0, 28 days from the start of the study
|
Frequency of stool(week)
|
0, 28 days from the start of the study
|
|
Fecal weight
Time Frame: 0, 28 days from the start of the study
|
weight of fecal
|
0, 28 days from the start of the study
|
|
Fecal pH
Time Frame: 0, 28 days from the start of the study
|
Fecal pH
|
0, 28 days from the start of the study
|
|
Fecal lactic acid
Time Frame: 0, 28 days from the start of the study
|
Short chain fatty acid(lactic acid)
|
0, 28 days from the start of the study
|
|
Fecal butyric acid
Time Frame: 0, 28 days from the start of the study
|
Short chain fatty acid
|
0, 28 days from the start of the study
|
|
Fecal propionic acid
Time Frame: 0, 28 days from the start of the study
|
Short chain fatty acid
|
0, 28 days from the start of the study
|
|
Fecal β-glucuronidase
Time Frame: 0, 28 days from the start of the study
|
Fecal enzyme
|
0, 28 days from the start of the study
|
|
Fecal urease
Time Frame: 0, 28 days from the start of the study
|
Fecal enzyme
|
0, 28 days from the start of the study
|
|
Fecal β-glucosidase
Time Frame: 0, 28 days from the start of the study
|
Fecal enzyme
|
0, 28 days from the start of the study
|
|
Bowel movement
Time Frame: 28 days from the start of the study
|
The bowel movement questionnire includes the defecation frequency, bowel time, fecal color, degree of difficulty in defecation and abdominal symptom
|
28 days from the start of the study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2012
Primary Completion (Actual)
August 1, 2012
Study Completion (Actual)
August 1, 2013
Study Registration Dates
First Submitted
August 28, 2013
First Submitted That Met QC Criteria
August 30, 2013
First Posted (Estimate)
September 2, 2013
Study Record Updates
Last Update Posted (Actual)
December 24, 2019
Last Update Submitted That Met QC Criteria
December 20, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CTCF2_2012_RP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Functional Constipation
-
Institute of Medical Sciences and SUM HospitalNot yet recruitingFunctional Constipation | Constipation - Functional | Constipation Chronic Idiopathic | Fecal Impaction | Pediatric Functional ConstipationIndia
-
Liaquat University of Medical & Health SciencesUniversità degli Studi dell'InsubriaNot yet recruiting
-
Universidad de AntioquiaNot yet recruitingConstipation - Functional
-
Eskisehir Osmangazi UniversitySehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research HospitalCompletedConstipation - FunctionalTurkey (Türkiye)
-
Ahi Evran University Education and Research HospitalActive, not recruitingConstipation - FunctionalTurkey (Türkiye)
-
Wecare Probiotics Co., Ltd.Not yet recruiting
-
Federal University of Minas GeraisMax NutriRecruiting
-
Peking Union Medical College HospitalInstitute of Process Engineering, Chinese Academy of SciencesNot yet recruitingChronic Constipation | Constipation - Functional | Fecal Microbiota TransplantationChina
-
Peking Union Medical College HospitalRecruitingChronic Constipation | Constipation - Functional | Fecal Microbiota Transplantation (FMT)China
-
Zeynep Idil SevimliNot yet recruitingFunctional Constipation (FC)Turkey (Türkiye)
Clinical Trials on Experimental Diet
-
Marjukka KolehmainenLund University; Uppsala University; Aarhus University Hospital; University of... and other collaboratorsCompletedCardiovascular Diseases | Insulin Resistance | Type 2 Diabetes | Impaired Glucose Tolerance | Abdominal ObesitySweden, Denmark, Finland, Iceland, Norway
-
University of LausanneUniversity of LiegeCompletedHereditary Fructose IntoleranceBelgium
-
Laval UniversityCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation...CompletedCardiovascular DiseasesCanada
-
Wake Forest University Health SciencesNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...Completed
-
Universitätsmedizin MannheimCompletedQuality of LifeGermany
-
Hospital Universitario Virgen de la ArrixacaUniversidad de Murcia; Sociedad Española de Endocrinología y Nutrición; Instituto...Not yet recruiting
-
Biruni UniversityCompleted
-
Clinica Universidad de Navarra, Universidad de...Recruiting
-
University of MichiganMichigan Nutrition Obesity Research CenterNot yet recruitingClostridioides Difficile InfectionUnited States
-
Milton S. Hershey Medical CenterStanley Medical Research InstituteCompleted